T-cell prolymphocytic leukemia
MONDO:0019468A slow-growing type of leukemia (blood cancer) in which too many lymphocytes are found in the bone marrow and/or blood. The T-cell is specified as the defective cell line.
Also known as: CLL, T-cell, T cell CLL, T cell chronic lymphocytic leukaemia, T cell chronic lymphocytic leukemia, T cell prolymphocytic leukaemia, T cell prolymphocytic leukemia, T prolymphocytic leukaemia, T prolymphocytic leukemia
1983 clinical trials for this condition and its sub-types, 17 tagged with T-cell prolymphocytic leukemia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Engineered donor cells take aim at tough blood cancers in early trial
Disease control PausedThis early-phase trial tests a new type of immune cell therapy called WU-CART-007 for people with certain blood cancers, including acute myeloid leukemia and T-cell lymphoma, that have come back or not responded to treatment. The therapy uses donor cells that are genetically modi…
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New drug may make stem cell transplants safer for older patients
Disease control OngoingThis early-phase trial tests whether the drug itacitinib can prevent cytokine release syndrome (a severe inflammatory reaction) after a mini stem cell transplant in people aged 60 and older with certain blood cancers. The study also aims to see if itacitinib allows doctors to use…
Phase 1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 26, 2026 18:40 UTC